Neurotransmitter Modulation BPC-157 has demonstrated modulatory effects on serotonergic, dopaminergic, and GABAergic neurotransmitter systems in CNS research models including an anti-serotonin syndrome profile and modulation of dopamine system activity expanding its research utility beyond peripheral tissue into neurobiological applications
Ricci G, De Maria F, Antonini G, Turella P, Bullo A, Stella L et al
No clinical studies
GHK-Cu and BPC-157 can typically be combined without issues, which simplifies administration for those using both
A phase II human trial was initiated for ulcerative colitis, with encouraging preliminary results
TRIM46 Contributes to High Glucose-Induced Ferroptosis and Cell Growth Inhibition in Human Retinal Capillary Endothelial Cells by Facilitating GPX4 Ubiquitination